Dendritic cell immunotherapy
DC3-HRPC, October 2001
Phase 3 small_molecule terminated
Quick answer
Dendritic cell immunotherapy for Prostate Cancer is a Phase 3 program (small_molecule) at NORTHWEST BIOTHERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NORTHWEST BIOTHERAPEUTICS INC
- Indication
- Prostate Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated